Stroke Trial, Recruiting NCT07593313 Sponsor: Nanchong Central Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07593313
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with central post-stroke pain (a type of pain caused by damage to the brain or nervous system from a stroke), based on recognised international medical guidelines
  • People whose stroke has been confirmed by a brain scan (CT or MRI)
  • People whose pain appeared after their stroke and is felt in areas of the body that match where the stroke caused damage
  • People whose pain has neuropathic characteristics — for example, burning, electric shock-like, or needle prick sensations
  • People whose pain has no other medical explanation
  • People aged 18 or older
  • People who have had pain for at least 3 months
  • People whose pain rates at 4 or more out of 10 on a standard pain scale
  • People who have complete medical records and have been followed up for at least 6 months

Who may not be able to join:

  • People who had ongoing chronic pain before their stroke occurred
  • People with severe memory or thinking difficulties that make it hard to participate in pain assessments (based on a standard cognitive test score below 15)
  • People for whom spinal cord stimulation treatment would not be safe — for example, those with blood clotting disorders, active infections, or mental health conditions that would prevent cooperation with the procedure
  • People with cancer or another serious illness where life expectancy is less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18404999336

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanchong Central Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Numerical Rating Scale (NRS) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov